CDH17 and neoplasm: To further confirm that CDH17 nanobody‐engineered OMVs enhance tumour selectivity and minimise off‐target accumulation, we employed the more sensitive near‐infrared (NIR)‐II imaging system using ICG‐conjugated OMVs.